Subscribe

Global X - S&P Biotech ETF (CURE.AX)

AUD77.73 -2.70 (-3.36%)
ASX AUD AU Equity
NAV AUD 77.91 -0.23% vs NAV as of 2026-07-13
AUM AUD 51.73M
TER 0.45%
Yield (TTM)
Distribution
52-week range 44.58 – 80.43
Holdings 149
Issuer Global X

About this ETF

The Global X S&P Biotech ETF, identified by its ticker CURE, endeavors to replicate the overall financial performance, encompassing both capital gains and dividends, of the S&P Biotechnology Select Industry Index, before any management fees and operational costs are deducted.

ISIN AU0000028110
Issuer Global X
Domicile AU
Inception 2018-11-08
Asset class Equity

Price

Top 10 holdings

APOGEE THERAPEUT APGE 1.49%
KYMERA THERAPEUT KYMR 1.41%
MODERNA INC MRNA 1.37%
VIKING THERAPEUT VKTX 1.29%
ERASCA INC ERAS 1.28%
CG ONCOLOGY INC CGON 1.27%
ORUKA THERAPEUTI ORKA 1.25%
PRAXIS PRECISION PRAX 1.25%
TWIST BIOSCIENCE TWST 1.24%
SPYRE THERAPEUTI SYRE 1.20%
See full holdings →